BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31512216)

  • 1. Breeding Strategies for Genetically Modified Mice.
    Parker-Thornburg J
    Methods Mol Biol; 2020; 2066():163-169. PubMed ID: 31512216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient generation of zebrafish maternal-zygotic mutants through transplantation of ectopically induced and Cas9/gRNA targeted primordial germ cells.
    Zhang F; Li X; He M; Ye D; Xiong F; Amin G; Zhu Z; Sun Y
    J Genet Genomics; 2020 Jan; 47(1):37-47. PubMed ID: 32094061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotyping Genetically Modified (GM) Mice.
    Aryal NK; Parker-Thornburg J
    Methods Mol Biol; 2020; 2066():133-148. PubMed ID: 31512214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Transgenic Mice Using CRISPR /Cas9 Technology.
    El Marjou F; Jouhanneau C; Krndija D
    Methods Mol Biol; 2021; 2214():125-141. PubMed ID: 32944907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct Generation of Conditional Alleles Using CRISPR/Cas9 in Mouse Zygotes.
    Pritchard CEJ; Kroese LJ; Huijbers IJ
    Methods Mol Biol; 2017; 1642():21-35. PubMed ID: 28815491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53 ICE CRIM mouse: a tool to generate mutant allelic series in somatic cells and germ lines for cancer studies.
    Fan HH; Yu IS; Lin YH; Wang SY; Liaw YH; Chen PL; Yang TL; Lin SW; Chen YT
    FASEB J; 2019 Apr; 33(4):5571-5584. PubMed ID: 30640520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins.
    Quadros RM; Miura H; Harms DW; Akatsuka H; Sato T; Aida T; Redder R; Richardson GP; Inagaki Y; Sakai D; Buckley SM; Seshacharyulu P; Batra SK; Behlke MA; Zeiner SA; Jacobi AM; Izu Y; Thoreson WB; Urness LD; Mansour SL; Ohtsuka M; Gurumurthy CB
    Genome Biol; 2017 May; 18(1):92. PubMed ID: 28511701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generating Genetically Modified Mice: A Decision Guide.
    Huijbers IJ
    Methods Mol Biol; 2017; 1642():1-19. PubMed ID: 28815490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9-Mediated Insertion of loxP Sites in the Mouse Dock7 Gene Provides an Effective Alternative to Use of Targeted Embryonic Stem Cells.
    Bishop KA; Harrington A; Kouranova E; Weinstein EJ; Rosen CJ; Cui X; Liaw L
    G3 (Bethesda); 2016 Jul; 6(7):2051-61. PubMed ID: 27175020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of the production of knock-in alleles by CRISPR/Cas9 microinjection into the mouse zygote.
    Raveux A; Vandormael-Pournin S; Cohen-Tannoudji M
    Sci Rep; 2017 Feb; 7():42661. PubMed ID: 28209967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing Genetically Engineered Mouse Models (GEMMs) Using CRISPR Mediated Genome Editing.
    Desjardins J; Cowan M; Yamanaka Y
    Methods Mol Biol; 2022; 2429():515-531. PubMed ID: 35507186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of Two Noradrenergic-Specific Dopamine-Beta-Hydroxylase-FLPo Knock-In Mice Using CRISPR/Cas9-Mediated Targeting in Embryonic Stem Cells.
    Sun JJ; Ray R
    PLoS One; 2016; 11(7):e0159474. PubMed ID: 27441631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroporation of Cas9 protein/sgRNA into early pronuclear zygotes generates non-mosaic mutants in the mouse.
    Hashimoto M; Yamashita Y; Takemoto T
    Dev Biol; 2016 Oct; 418(1):1-9. PubMed ID: 27474397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
    Vermersch E; Jouve C; Hulot JS
    Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-mediated reporter knock-in in mouse haploid embryonic stem cells.
    Kimura Y; Oda M; Nakatani T; Sekita Y; Monfort A; Wutz A; Mochizuki H; Nakano T
    Sci Rep; 2015 Jun; 5():10710. PubMed ID: 26039937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Mutations in the Mouse via Embryonic Stem Cells.
    Gertsenstein M; Mianné J; Teboul L; Nutter LMJ
    Methods Mol Biol; 2020; 2066():59-82. PubMed ID: 31512207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zygote Electroporation for CRISPR/Cas9 Delivery to Generate Genetically Modified Mice.
    Takemoto T
    Methods Mol Biol; 2020; 2050():121-126. PubMed ID: 31468486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9 mediated genome editing in ES cells and its application for chimeric analysis in mice.
    Oji A; Noda T; Fujihara Y; Miyata H; Kim YJ; Muto M; Nozawa K; Matsumura T; Isotani A; Ikawa M
    Sci Rep; 2016 Aug; 6():31666. PubMed ID: 27530713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
    Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
    Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Editing of Mouse Embryonic and Epiblast Stem Cells.
    Sibbritt T; Osteil P; Fan X; Sun J; Salehin N; Knowles H; Shen J; Tam PPL
    Methods Mol Biol; 2019; 1940():77-95. PubMed ID: 30788819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.